In HCC patients, elevated serum AFP level is positively correlated with poor differentiation, microvascular invasion and tumor recurrence (23, 24), which is consistent with the biological behavior of CK19-positive HCCs with high aggression. This evidence concerns the gene AFP and hepatocellular carcinoma.